Literature DB >> 11518230

Complex interaction of ergovaline with 5-HT2A, 5-HT1B/1D, and alpha1 receptors in isolated arteries of rat and guinea pig.

C Schöning1, M Flieger, H H Pertz.   

Abstract

Vascular effects of ergovaline mediated by 5-hydroxytryptamine(HT)2A, 5-HT1B/1D, and alpha1 receptors were studied in isolated arterial preparations of rat and guinea pig. In rat tail artery ergovaline behaved as a potent contractile partial agonist showing an agonist potency (pEC50) of 8.86 +/- 0.03, a maximum response (Emax) of 59 +/- 2% with respect to 5-HT, and a partial agonist affinity (pK(P)) of 8.51 +/- 0.06. Ergovaline was equipotent with ergotamine (pEC50, 8.69 +/- 0.07; Emax, 52 +/- 4%; pK(P), 8.36 +/- 0.11). Contractile responses to ergovaline and ergotamine were surmountably antagonized by the 5-HT2A receptor antagonist ketanserin (3 nM). Antagonist affinity (apparent pA2) for ketanserin against ergovaline and ergotamine was 9.19 +/- 0.08 and 9.36 +/- 0.17, respectively. Ergovaline showed extremely slow on-set and off-set kinetics in rat tail artery. The construction of cumulative concentration-response curves required about 4 h, and the contractile response to ergovaline (30 nM), which completely abolished the subsequent contractile response to 5-HT (10 nM to 1 mM), could not be reversed by wash-out. In guinea pig iliac artery moderately precontracted with prostaglandin F2alpha (0.05 to 0.5 microM) ergovaline behaved as an agonist (pEC50, 7.71 +/- 0.10) with a potency similar to that of 5-HT (pEC50, 7.60 +/- 0.05). The contractile response to ergovaline was inhibited by the 5-HT1B/1D receptor antagonist GR127935 (10 nM). The apparent pA2 value for GR127935 against ergovaline was 8.90 +/- 0.12. Ergovaline (10 nM) produced no contractile response in guinea pig iliac artery when added before the PGF2alpha-induced precontraction but caused insurmountable blockade of the contractile response to the 5-HT1B/1D receptor agonist 5-carboxamidotryptamine (5-CT). The apparent pA2 value for ergovaline against 5-CT was 8.56 +/- 0.18. In rat thoracic aorta ergovaline (2 microM) activated alpha1 adrenoceptors only with low efficacy (Emax, 12 +/- 3%) but surmountably antagonized norepinephrine-induced contractions with a pK(P) of 7.07 +/- 0.12. It is concluded that the powerful constrictor effect of ergovaline mediated by activation of vascular 5-HT2A and 5-HT1B/1D receptors may explain the vascular symptoms of fescue toxicosis observed in livestock grazing tall fescue pastures infected with the endophytic fungus Neotyphodium coenophialum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518230     DOI: 10.2527/2001.7982202x

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  21 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  Effects of grazing different ergovaline concentrations on vasoactivity of bovine lateral saphenous vein.

Authors:  James L Klotz; Glen E Aiken; Amanda M Egert-McLean; F Neal Schrick; Nabanita Chattopadhyay; David L Harmon
Journal:  J Anim Sci       Date:  2018-06-29       Impact factor: 3.159

3.  Ergot alkaloid exposure during gestation alters: II. Uterine and umbilical artery vasoactivity1.

Authors:  James L Klotz; Jessi L Britt; Markus F Miller; Miriam A Snider; Glen E Aiken; Nathan M Long; Scott L Pratt; John G Andrae; Susan K Duckett
Journal:  J Anim Sci       Date:  2019-04-03       Impact factor: 3.159

4.  Ergot alkaloid exposure during gestation alters. I. Maternal characteristics and placental development of pregnant ewes1.

Authors:  Jessica L Britt; Maslyn A Greene; William C Bridges; James L Klotz; Glen E Aiken; John G Andrae; Scott L Pratt; Nathan M Long; F N Schrick; James R Strickland; Sarah A Wilbanks; Markus F Miller; Brandon M Koch; Susan K Duckett
Journal:  J Anim Sci       Date:  2019-04-03       Impact factor: 3.159

5.  Tall fescue ergot alkaloids are vasoactive in equine vasculature.

Authors:  J L Klotz; K J McDowell
Journal:  J Anim Sci       Date:  2017-11       Impact factor: 3.159

6.  Interaction of ergovaline with serotonin receptor 5-HT2A in bovine ruminal and mesenteric vasculature.

Authors:  Ronald J Trotta; David L Harmon; James L Klotz
Journal:  J Anim Sci       Date:  2018-11-21       Impact factor: 3.159

7.  Involvement of signaling pathways in bovine sperm motility, and effect of ergot alkaloids.

Authors:  Hehai Wang; Michael L Looper; Zelpha B Johnson; Rick W Rorie; Charles F Rosenkrans
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-05-19       Impact factor: 2.416

8.  Pharmacological properties of a wide array of ergolines at functional alpha(1)-adrenoceptor subtypes.

Authors:  Tilo Görnemann; Sven Jähnichen; Björn Schurad; Klaus Peter Latté; Reinhard Horowski; Johannes Tack; Miroslav Flieger; Heinz H Pertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-08       Impact factor: 3.000

9.  Ergot alkaloids reduce circulating serotonin in the bovine.

Authors:  Eriton E L Valente; James L Klotz; Gyuchul Ahn; Kyle R McLeod; Hannah M Herzing; Mindy King; David L Harmon
Journal:  J Anim Sci       Date:  2020-12-01       Impact factor: 3.159

10.  The effect of ergot alkaloid exposure during gestation on the microscopic morphology and vasculature of the ovine placenta.

Authors:  J L Britt; R R Powell; C McMahan; T F Bruce; S K Duckett
Journal:  J Histotechnol       Date:  2021-04-29       Impact factor: 0.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.